Skip to content
Open access

C-reactive protein–triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with H-type hypertension

Aug 2026 · Cardiovascular Diabetology · Vol 25 · 0 citations · 62 references
Medicine

TL;DR

CTI is an independently associated factor for coronary stenosis severity in patients with hypertension, particularly in those with H-type hypertension and comorbid diabetes, and holds promise as a practical tool for early risk stratification and for guiding individualized prevention strategies.

Abstract

The C-reactive protein–triglyceride glucose index (CTI) is a novel composite biomarker that integrates inflammation and insulin resistance. However, its association with the severity of coronary artery disease (CAD) in patients with H-type hypertension under different glucose metabolism statuses remains unclear. This retrospective study enrolled 1392 hypertensive patients who underwent coronary angiography. CTI was calculated as 0.412 × ln(CRP[mg/L]) + ln(TG[mg/dL] × FPG [mg/dL]/2). Patients were divided into three groups according to CTI tertiles: T1 group (6.748 ≤ CTI < 8.674), T2 group (8.674 ≤ CTI < 9.549), and T3 group (9.549 ≤ CTI ≤ 12.713). Based on the Gensini score derived from coronary angiography, the study cohort was divided into three groups according to the severity of stenosis: low stenosis, medium stenosis, and high stenosis. Logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curve analysis were used to investigate the association between CTI and CAD severity across different glucose metabolism statuses and H‑type hypertension subgroups. Incremental utility of CTI was evaluated using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA). The results show that CTI is significantly associated with CAD severity in hypertensive patients. After adjusting for risk factors, CTI remained significantly associated with multi-vessel CAD (OR = 2.155, 95%CI 1.839–2.455) and moderate-to-severe coronary stenosis (OR = 1.818, 95% CI 1.603–2.062). RCS analysis revealed a linear dose–response relationship between CTI and CAD severity (P for non-linearity > 0.05). Notably, we observed significant interaction between CTI and H-type hypertension on CAD severity (P = 0.033). Under different glycemic statuses, high CTI levels were associated with CAD severity; however, no association between CTI and moderate‑to‑severe coronary stenosis was observed in patients with diabetes mellitus (DM). In the DM subgroup of patients with H-type hypertension, after adjustment for risk factors, patients in the T3 group had a 6.475-fold increased risk of multi-vessel CAD compared with those in the T1 group (95% CI 1.693–24.773, P = 0.006). ROC analysis demonstrated that, across different glucose metabolism subgroups, CTI showed the highest discriminative ability for multi‑vessel CAD in patients with H‑type hypertension and comorbid DM (AUC = 0.712, 95% CI 0.619–0.804, P < 0.001). CTI is an independently associated factor for coronary stenosis severity in patients with hypertension, particularly in those with H‑type hypertension and comorbid diabetes. This simple and cost‑effective composite biomarker holds promise as a practical tool for early risk stratification and for guiding individualized prevention strategies.

Read PDF

Similar papers

Sep 2026

Joint association of high-sensitivity C-reactive protein-triglyceride glucose index and coronary artery calcification with adverse outcomes in patients with coronary artery disease: a large-scale cohort study.

In patients with CAD, elevated CTI and MSCAC independently portend adverse outcomes, and their coexistence identifies a particularly high‑risk phenotype, which supports the complementary value of metabolic‑inflammatory and anatomic measures in risk stratification.

Song Wen, Zhan-Yuan Chen, Rui Fu et al. · 0 citations
Open access Aug 2026

Association of the c-reactive protein-triglyceride glucose index with myocardial ischemia in patients with minimal to moderate coronary artery disease

Objective This study sought to explore the relationship between the C-reactive protein-triglyceride-glucose index (CTI) and the incidence of myocardial ischemia in patients with minimal to moderate coronary artery disease (CAD). Methods The research retrospectively included 707 patients who underwent coronary computed...

Zeng-Fa Huang, Beibei Cao, Xiao-Yu Liu et al. · 0 citations
Open access Oct 2026

C-reactive protein–triglyceride-glucose index and diabetic vascular complications risk among patients with diabetes: a national cohort study

Abstract Introduction The C-reactive protein–triglyceride-glucose index (CTI) has emerged as an innovative biomarker for insulin resistance and inflammatory processes. Nevertheless, the association between CTI and diabetic vascular complications (DVCs) and its subtypes in individuals with diabetes remains unclear. Meth...

Shi-Kai Xiong, Hao Wang, Bin Wang et al. · 0 citations
Open access Oct 2026

Association of the C-Reactive Protein–Triglyceride–Glucose Index with Kidney Injury in Patients with Coronary Heart Disease: A Two-Center Cross-Sectional Study

Background The composite index of inflammation and insulin resistance (IR), the C-reactive protein (CRP)–triglyceride–glucose (TyG) index (CTI), has been suggested to be closely associated with cardiovascular disease. However, the relationship between the CTI and kidney injury (KI), including its subtypes [declined kid...

Meng-Meng Fan, Xue-Ping Zhang, Xian-Wei Tian et al. · 0 citations
Open access Sep 2026

C-reactive protein–triglyceride–glucose index and diabetes status for risk stratification in stage 4 cardiovascular–kidney–metabolic syndrome with acute decompensated heart failure: a retrospective cohort study

In patients with stage 4 CKM syndrome hospitalized for ADHF, elevated CTI was associated with higher risks of all-cause mortality and MACCEs, with the greatest risk in patients with both diabetes and high CTI.

Wei Wang, Jia-Ming Zhang, Miao-Xin Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.